eCourse
Patent Eligible Subject Matter: Significant Cases Impacting Software and Current Perspectives in Life Sciences
Contains material from Mar 2018
Patent Eligible Subject Matter: Significant Cases Impacting Software and Current Perspectives in Life Sciences
4.5 out of 5 stars
What was the overall quality of the course (presentation, materials, and technical delivery)?
Rate the overall teaching effectiveness and presentation skills of faculty for the course.
How would you rate the value of the materials provided as part of the course?
Technical Questions?
512.475.6700
service@utcle.org
Session 1: Section 101: Software and High Tech - Alice v. CLS changed the way we, the Federal Circuit, and the USPTO look at Section 101. The law is developing in our common law tradition. But it's important to stay up to date with the latest case law to most effectively refute Section 101 rejections. Review the current state of the law in this evolving area.
Session 2: Section 101: Life Sciences - The United States (U.S.) America Invents Act (AIA) of 2011 did not amend the patent subject matter eligibility standards under 35 U.S.C. § 101. Yet, despite the AIA’s goal to provide greater global patent law harmonization, the current state of patent subject matter eligibility law in the U.S. is decidedly not aligned with this long-standing effort. Review the current status of U.S. subject matter eligibility for life sciences, hear how it compares with major international jurisdictions, and explore proposed legislative solutions to address the ongoing negative impact on the U.S. life sciences industry.
Session 2: Section 101: Life Sciences - The United States (U.S.) America Invents Act (AIA) of 2011 did not amend the patent subject matter eligibility standards under 35 U.S.C. § 101. Yet, despite the AIA’s goal to provide greater global patent law harmonization, the current state of patent subject matter eligibility law in the U.S. is decidedly not aligned with this long-standing effort. Review the current status of U.S. subject matter eligibility for life sciences, hear how it compares with major international jurisdictions, and explore proposed legislative solutions to address the ongoing negative impact on the U.S. life sciences industry.
Includes: Audio Slides
Preview mode.
You must be signed in, have purchased this eCourse,
and the eCourse must be active
to have full access.
Preview Sessions
Show session details
1.
Section 101: Software and High Tech (Mar 2018)
Robert Bahr, Dale S. Lazar
0.75
0.00
0.00
Preview Materials
Download session materials for offline use
Session 1
—44 mins
Section 101: Software and High Tech (Mar 2018)
Alice v. CLS changed the way we, the Federal Circuit, and the USPTO look at Section 101. The law is developing in our common law tradition. But it's important to stay up to date with the latest case law to most effectively refute Section 101 rejections. Review the current state of the law in this evolving area.
Originally presented: Mar 2018 Advanced Patent Law Institute
Robert Bahr,
U.S. Patent and Trademark Office - Alexandria, VA
Dale S. Lazar,
DLA Piper LLP US - Reston, VA
Show session details
2.
Section 101: Life Sciences (Mar 2018)
Leslie Fischer, Courtney Stopp
0.75
0.00
0.00
Preview Materials
Download session materials for offline use
Slides
(pdf)
5 pgs
Session 2
—38 mins
Section 101: Life Sciences (Mar 2018)
The United States (U.S.) America Invents Act (AIA) of 2011 did not amend the patent subject matter eligibility standards under 35 U.S.C. § 101. Yet, despite the AIA’s goal to provide greater global patent law harmonization, the current state of patent subject matter eligibility law in the U.S. is decidedly not aligned with this long-standing effort. Review the current status of U.S. subject matter eligibility for life sciences, hear how it compares with major international jurisdictions, and explore proposed legislative solutions to address the ongoing negative impact on the U.S. life sciences industry.
Originally presented: Mar 2018 Advanced Patent Law Institute
Leslie Fischer,
Novartis Pharmaceuticals Corporation - East Hanover, NJ
Courtney Stopp,
U.S. Patent and Trademark Office - Alexandria, VA